The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson's disease
Authors:
- 25 June 2024
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 222, 386-396
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potentialAgeing Research Reviews, 2023
- Rethinking IRPs/IRE system in neurodegenerative disorders: Looking beyond iron metabolismAgeing Research Reviews, 2022
- Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson's diseaseFree Radical Biology and Medicine, 2020
- Parkinson's disease–related increase of ‐weighted hypointensity in substantia nigra pars compactaMovement Disorders, 2016
- Brain Iron Metabolism Dysfunction in Parkinson’s DiseaseMolecular Neurobiology, 2016
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's DiseaseCell, 2010
- Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout miceMolecular Brain Research, 2005
- p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonismAnnals of Neurology, 2002